Status | Study |
Recruiting |
Study Name: Laser Tissue Welding - Distal Pancreatectomy Sealing Study Condition: Pancreatic Tumor, Benign Pancreatic Neoplasms Pancreatic A Date: 2017-05-08 Interventions: Device: Distal Pancreatectomy Sealing Using LTW The device's intended use is to seal the pancreatic surf |
Enrolling by invitation |
Study Name: YF476 and Type II Gastric Carcinoids Condition: Zollinger-Ellison Syndrome Date: 2015-05-13 Interventions: Drug: YF476 Gastrin receptor antagonist Other Name: |
Terminated |
Study Name: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer Condition: Estrogen Receptor-positive Breast Cancer Gastrinoma Date: 2014-10-22 Interventions: Drug: Everolimus Given PO Other Names: |
Recruiting |
Study Name: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2014-10-03 Interventions: Drug: regorafenib Given PO |
Completed |
Study Name: A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases Condition: Gastric Ulcer (GU) Duodenal Ulcer (DU) Anastomotic Ulcer ( Date: 2014-05-30 Interventions: Drug: D961H sachet 10 mg Drug: D961H capsu |
Withdrawn |
Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2014-01-07 Interventions: Drug: dovitinib lactate Given |
Terminated |
Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Condition: Gastrinoma Glucagonoma Insuli Date: 2014-01-07 Interventions: Drug: everolimus Given PO |
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2013-04-02 Interventions: Drug: temozolomide Given PO |
Active, not recruiting |
Study Name: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Condition: Gastrinoma Glucagonoma Insuli Date: 2012-01-10 Interventions: Drug: capecitabine Given PO |
Completed |
Study Name: Nexium Capsules Clinical Experience Investigation Condition: Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndrome Date: 2011-09-14 |